Literature DB >> 22197426

Distal myopathies--new genetic entities expand diagnostic challenge.

Bjarne Udd1.   

Abstract

Distal myopathies are a group of muscle diseases which share the clinical pattern of predominant weakness in the feet and/or hands. Rapid advance in the understanding of underlying gene defects have to date separated more than 20 distinct disorders and many are yet without genetic characterisation. No definite diagnosis can be made on other grounds than identification of the final molecular genetic defect. Besides usual investigations including EMG and muscle biopsy, muscle imaging is very important in defining the precise pattern of muscle involvement. Based on the combination of age at onset, mode of inheritance, pathology and muscle imaging, the number of underlying candidate genes for a certain disease can be significantly reduced, which is of help for the molecular genetic approach.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22197426     DOI: 10.1016/j.nmd.2011.10.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  23 in total

Review 1.  T-cell intracellular antigens in health and disease.

Authors:  Carmen Sánchez-Jiménez; José M Izquierdo
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  A new early-onset neuromuscular disorder associated with kyphoscoliosis peptidase (KY) deficiency.

Authors:  Carola Hedberg-Oldfors; Niklas Darin; Mia Olsson Engman; Zacharias Orfanos; Christer Thomsen; Peter F M van der Ven; Anders Oldfors
Journal:  Eur J Hum Genet       Date:  2016-08-03       Impact factor: 4.246

3.  Novel Mutation of the GNE Gene Presenting Atypical Mild Clinical Feature: A Korean Case Report.

Authors:  Young-Ah Choi; Sung-Hye Park; Youbin Yi; Keewon Kim
Journal:  Ann Rehabil Med       Date:  2015-06-30

4.  SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles.

Authors:  Robert C Bucelli; Khalid Arhzaouy; Alan Pestronk; Sara K Pittman; Luisa Rojas; Carolyn M Sue; Anni Evilä; Peter Hackman; Bjarne Udd; Matthew B Harms; Conrad C Weihl
Journal:  Neurology       Date:  2015-07-24       Impact factor: 9.910

5.  Formation of gelsolin amyloid fibrils in the rough endoplasmic reticulum of skeletal muscle in the gelsolin mouse model of inclusion body myositis: comparative analysis to human sporadic inclusion body myositis.

Authors:  Sergei I Bannykh; William E Balch; Jeffery W Kelly; Lesley J Page; G Diane Shelton
Journal:  Ultrastruct Pathol       Date:  2013-10       Impact factor: 1.094

6.  Muscle MRI in muscular dystrophies.

Authors:  Jordi Díaz-Manera; Jaume Llauger; Eduard Gallardo; Isabel Illa
Journal:  Acta Myol       Date:  2015-12

7.  Anoctamin 5 muscular dystrophy in Denmark: prevalence, genotypes, phenotypes, cardiac findings, and muscle protein expression.

Authors:  Nanna Witting; Morten Duno; Helle Petri; Thomas Krag; Henning Bundgaard; Lars Kober; John Vissing
Journal:  J Neurol       Date:  2013-05-14       Impact factor: 4.849

Review 8.  Distal myopathies.

Authors:  Bjarne Udd
Journal:  Curr Neurol Neurosci Rep       Date:  2014-03       Impact factor: 5.081

9.  [Myofibrillary myopathy due to the ZASP mutation Ala147Thr : two cases with exclusively distal leg involvement].

Authors:  T Kraya; W Kress; D Stoevesant; M Deschauer; S Zierz
Journal:  Nervenarzt       Date:  2013-02       Impact factor: 1.214

Review 10.  Genome engineering: a new approach to gene therapy for neuromuscular disorders.

Authors:  Christopher E Nelson; Jacqueline N Robinson-Hamm; Charles A Gersbach
Journal:  Nat Rev Neurol       Date:  2017-09-29       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.